-
- 抗原 See all CHRNB3 抗体
- CHRNB3 (Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3))
-
抗原表位
- AA 119-230
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CHRNB3 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- 特异性
- The antibody is a rabbit polyclonal antibody raised against CHRNb3. It has been selected for its ability to recognize CHRNb3 in immunohistochemical staining and western blotting.
- 纯化方法
- Antigen-specific affinity chromatography
- 免疫原
- CHRNb3 (Glu119-Arg230)
- 亚型
- IgG
- Top Product
- Discover our top product CHRNB3 Primary Antibody
-
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 67-218) antibody
CHRNB3 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 25-232) antibodyCHRNB3 适用: 人 WB, ELISA, IHC, ICC, FACS, Neut 宿主: 小鼠 Monoclonal 4C1H2 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 128-223) antibodyCHRNB3 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 3G6 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (Internal Region) antibodyCHRNB3 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 176-225) antibodyCHRNB3 适用: 人, 小鼠, 大鼠, 犬, 豚鼠, 兔, Cow, 小鸡, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (AA 187-200) antibodyCHRNB3 适用: Hamster WB 宿主: 兔 Polyclonal RB49738 unconjugated
anti-Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3) (Internal Region) antibodyVerified CHRNB3 适用: 人 WB, ELISA 宿主: 山羊 Polyclonal unconjugated
-
- 应用备注
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- 说明
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- 储存液
- Sodium azide
- 注意事项
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- 4 °C
- 储存方法
- Store at 2-8 °C for one month. Aliquot and store at -80 °C for 12 months.
- 有效期
- 12 months
-
- 抗原
- CHRNB3 (Cholinergic Receptor, Nicotinic, beta 3 (Neuronal) (CHRNB3))
- 别名
- Cholinergic Receptor, Nicotinic, Beta 3 (CHRNB3 产品)
- 别名
- 5730417K16Rik antibody, Acrb3 antibody, NACHR antibody, CHRNB3 antibody, chrnb3 antibody, cholinergic receptor nicotinic beta 3 subunit antibody, neuronal acetylcholine receptor subunit beta-3 antibody, cholinergic receptor, nicotinic, beta polypeptide 3 antibody, cholinergic receptor, nicotinic beta 3 L homeolog antibody, cholinergic receptor, nicotinic beta 3 antibody, cholinergic receptor, nicotinic, beta 3b (neuronal) antibody, cholinergic receptor, nicotinic, beta polypeptide 3a antibody, CHRNB3 antibody, CpipJ_CPIJ012638 antibody, Chrnb3 antibody, chrnb3.L antibody, chrnb3 antibody, chrnb3b antibody, chrnb3a antibody
- 背景
- Alternative Names: CHR-NB3, CHRN-B3, N-AChRB3, NAChRB3, N-AChR-B3, Neuronal Acetylcholine Receptor Beta 3
-
You are here:
